Effect of rechallenge nivolumab in a hemodialysis patient with multiple metastases from a rapidly progressed T1a renal clear cell carcinoma: An autopsy case.
Kazushi HanawaNorifumi SawadaYuka YokotaJunki AikawaYuko OtakeKoki SugimuraHiroshi ShimuraTakanori MochizukiSatoru KiraTakahiko MitsuiPublished in: IJU case reports (2024)
Nivolumab has potential to control lung metastasis progression. Additionally, rechallenge is possible in patients with renal cell carcinoma undergoing hemodialysis.